Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Beijing Review: Seeing the Trend, Riding the Wave
-
Market Insights: How to Achieve Asset Value by Investing in ETH Contracts
-
The Rare Earth Revival: North America's Strategic Leap into Critical MineralsThe Rare Earth Revival: North America's Strategic Leap into Critical Minerals
-
Daiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to Address Persistent Gaps in the Management of Elevated LDL-C
-
Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C
-
PU Prime Adds Flexible Leverage to Copy Trading Platform
-
Bin Butlers Announces Orange County's First Trash Valet Service
-
SnapClaim Revolutionizes Diminished Value Appraisals with AI Driven Reports
-
CreditVeto Unveils Strategy for Scalable Growth in the Credit Repair Industry
-
Gemini and Ripple Launch XRP Credit Card; Rich Miner Cloud Mining Offers New Profit Opportunities for XRP Holders
-
Earn 3,000 XRP daily, no longer dependent on price fluctuations: BJMINING helps you get started easily
-
Grow London, London Stock Exchange and The Global City partner with London FinTech Summit to connect global finance capitals and drive cross-border collaboration
-
Republic Event Rentals Launches in Charleston, SC, Making Elegance Accessible for All Occasions
-
Textero.io Improves Usability All Over the Website
-
Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
-
Lucinn Unveils New Filtered Showerhead Aimed at Promoting Clearer Skin and Shinier HairâBacked by Advanced Filtration Technology
-
AI-Generated video "SCO Poetic Saga" released ahead of SCO Tianjin Summit
-
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
-
Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension
-
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
-
Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial
-
Harbin Cultural, Tourism and Sports Industry Expo & 2025 Harbin Marathon Expo Opens
-
Continuous Innovation: Locus GameChain Enters Commercialization Stage with Serverless Gaming Solution
-
No KYC. 100x Leverage. $50 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack.
-
Liposet Launches Revolutionary Health and Fitness Supplement Systems
-
Missouri State Athletics Partners with Elevate Entertainment as Official DJ Partner for 2025 Season
-
RWR's Clay Millican & Tony Schumacher Positioned for Top Fuel Glory with Associate Sponsor Keen's Buildings
-
Durham Philanthropist, Rebecca Feinglos, and Major Academic Medical Center Launch Groundbreaking Grief Initiative
-
FS Launches DCS-W Series Optical Circuit Switches to Power Next-Gen AI and HPC Networks
-
Affordable Birthday Celebrations at Kids Wonderland
-
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk
-
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in C
-
Sparta Releases Q3 2025 Financial Results
-
Grow London, London Stock Exchange and The Global City partner with London FinTech Summit to connect global finance capitals and drive cross-border collaboration
-
Grow London, London Stock Exchange and The Global City partner with London FinTech Summit to connect global finance capitals and drive cross-border collaboration
-
Cloud mining Services to Explode in 2025: FY Energy Offers an Effortless Way to Earn Crypto
-
Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension
-
15 Goranson Bain Ausley Attorneys Named Best Lawyers in America® 2026 for Family Law Mediation -- The Most in Texas and the United States
-
Everything Branding Launches AEO Growth Program to Secure AI-Recognized Press
-
Bybit x Santiment DeFi Report: Platform Tokens Shine As MNT Sees Over $1M Whale Transactions
-
Quick Fix Synthetic Warns Customers About Counterfeit Products and How to Avoid Them
-
CWP Productions: Your Partner for Unforgettable Events
-
Femarelle Rejuvenate: Support for Women in Their 40s and Beyond
-
Cardano (ADA) Momentum Highlights Market Rotation as MAGACOIN FINANCE Presale Records Consecutive Sellouts
-
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
-
Global Launch of AEROVENT ZERO: China-Developed Innovation Ushering Tech Textiles into a PFAS-Free Era
-
Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction
-
LgMining leads the new era of cloud mining Forecasts Bitcoin to Surpass 120K USD, Targeting 150K USD, and Ethereum to Hit 10K USD
-
$2 Billion Lower Amber Energy Bid Recommended by Special Master in CITGO Sale Process
-
Dr. Omar Massoud Scholarship for Future Doctors Opens Applications for Undergraduate Students Pursuing Medicine
